In cancer cells, MALAT1 can further disrupt the formation of a splicing modulator complex through hijacking the SFPQ factor (proline- and glutamine-rich SF; or PSF for PTB-associated SF), thereby inhibiting its interaction with the tumour growth factor PTBP2. The gene discussed is MALAT1; the disease is cancer.